25 XP   0   0   10

Novacyt
Buy, Hold or Sell?

Let's analyse Novacyt together

PenkeI guess you are interested in Novacyt. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Novacyt. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Novacyt

I send you an email if I find something interesting about Novacyt.

Quick analysis of Novacyt (30 sec.)










What can you expect buying and holding a share of Novacyt? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€1.90
Expected worth in 1 year
€0.15
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
€-1.75
Return On Investment
-220.4%

For what price can you sell your share?

Current Price per Share
€0.80
Expected price per share
€0.545 - €0.995
How sure are you?
50%

1. Valuation of Novacyt (5 min.)




Live pricePrice per Share (EOD)

€0.80

Intrinsic Value Per Share

€-1.67 - €3.67

Total Value Per Share

€0.23 - €5.57

2. Growth of Novacyt (5 min.)




Is Novacyt growing?

Current yearPrevious yearGrowGrow %
How rich?$143.6m$176.7m-$33.1m-23.1%

How much money is Novacyt making?

Current yearPrevious yearGrowGrow %
Making money-$27.6m-$12.1m-$15.5m-56.2%
Net Profit Margin-105.5%-10.2%--

How much money comes from the company's main activities?

3. Financial Health of Novacyt (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#121 / 334

Most Revenue
#142 / 334

Most Profit
#301 / 334

Most Efficient
#245 / 334

What can you expect buying and holding a share of Novacyt? (5 min.)

Welcome investor! Novacyt's management wants to use your money to grow the business. In return you get a share of Novacyt.

What can you expect buying and holding a share of Novacyt?

First you should know what it really means to hold a share of Novacyt. And how you can make/lose money.

Speculation

The Price per Share of Novacyt is €0.796. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Novacyt.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Novacyt, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €1.90. Based on the TTM, the Book Value Change Per Share is €-0.44 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Novacyt.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.45-57.0%-0.45-57.0%-0.17-21.6%0.3038.0%0.1012.3%
Usd Book Value Change Per Share-0.47-59.0%-0.47-59.0%-0.16-19.7%0.3341.3%0.2025.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.47-59.0%-0.47-59.0%-0.16-19.7%0.3341.3%0.2025.2%
Usd Price Per Share1.32-1.32-4.69-3.42-2.74-
Price to Earnings Ratio-2.90--2.90--27.30--6.45--13.92-
Price-to-Total Gains Ratio-2.80--2.80--29.86--7.22--2.19-
Price to Book Ratio0.65-0.65-1.87-1.72-4.60-
Price-to-Total Gains Ratio-2.80--2.80--29.86--7.22--2.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8518792
Number of shares1173
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.470.33
Usd Total Gains Per Share-0.470.33
Gains per Quarter (1173 shares)-550.65385.46
Gains per Year (1173 shares)-2,202.601,541.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2203-2213015421532
20-4405-4416030843074
30-6608-6619046264616
40-8810-8822061676158
50-11013-11025077097700
60-13216-13228092519242
70-15418-1543101079310784
80-17621-1763401233512326
90-19823-1983701387713868
100-22026-2204001541915410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.09.00.010.0%1.011.01.07.7%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%5.05.00.050.0%6.07.00.046.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%5.05.00.050.0%6.07.00.046.2%

Fundamentals of Novacyt

About Novacyt

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.

Fundamental data was last updated by Penke on 2024-04-09 12:42:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Novacyt.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Novacyt earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • A Net Profit Margin of -105.5% means that €-1.06 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Novacyt:

  • The MRQ is -105.5%. The company is making a huge loss. -2
  • The TTM is -105.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-105.5%TTM-105.5%0.0%
TTM-105.5%YOY-10.2%-95.4%
TTM-105.5%5Y-26.5%-79.1%
5Y-26.5%10Y-54.1%+27.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-105.5%-12.4%-93.1%
TTM-105.5%-20.4%-85.1%
YOY-10.2%-14.4%+4.2%
5Y-26.5%-21.3%-5.2%
10Y-54.1%-25.0%-29.1%
1.1.2. Return on Assets

Shows how efficient Novacyt is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • -15.8% Return on Assets means that Novacyt generated €-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Novacyt:

  • The MRQ is -15.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.8%TTM-15.8%0.0%
TTM-15.8%YOY-5.3%-10.5%
TTM-15.8%5Y1.7%-17.4%
5Y1.7%10Y-15.3%+17.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.8%-4.1%-11.7%
TTM-15.8%-4.7%-11.1%
YOY-5.3%-4.6%-0.7%
5Y1.7%-4.0%+5.7%
10Y-15.3%-5.2%-10.1%
1.1.3. Return on Equity

Shows how efficient Novacyt is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • -19.3% Return on Equity means Novacyt generated €-0.19 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Novacyt:

  • The MRQ is -19.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -19.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.3%TTM-19.3%0.0%
TTM-19.3%YOY-6.9%-12.4%
TTM-19.3%5Y2.3%-21.6%
5Y2.3%10Y-23.6%+25.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.3%-4.2%-15.1%
TTM-19.3%-5.8%-13.5%
YOY-6.9%-5.5%-1.4%
5Y2.3%-6.3%+8.6%
10Y-23.6%-7.1%-16.5%

1.2. Operating Efficiency of Novacyt.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Novacyt is operating .

  • Measures how much profit Novacyt makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • An Operating Margin of -78.9% means the company generated €-0.79  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Novacyt:

  • The MRQ is -78.9%. The company is operating very inefficient. -2
  • The TTM is -78.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-78.9%TTM-78.9%0.0%
TTM-78.9%YOY-1.4%-77.5%
TTM-78.9%5Y-11.9%-67.0%
5Y-11.9%10Y-41.9%+30.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-78.9%-24.3%-54.6%
TTM-78.9%-16.4%-62.5%
YOY-1.4%-14.0%+12.6%
5Y-11.9%-20.4%+8.5%
10Y-41.9%-24.8%-17.1%
1.2.2. Operating Ratio

Measures how efficient Novacyt is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.79 means that the operating costs are €1.79 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Novacyt:

  • The MRQ is 1.789. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.789. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.789TTM1.7890.000
TTM1.789YOY1.014+0.775
TTM1.7895Y1.063+0.726
5Y1.06310Y1.260-0.197
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7891.456+0.333
TTM1.7891.439+0.350
YOY1.0141.431-0.417
5Y1.0631.436-0.373
10Y1.2601.374-0.114

1.3. Liquidity of Novacyt.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Novacyt is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 5.25 means the company has €5.25 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Novacyt:

  • The MRQ is 5.250. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.250. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.250TTM5.2500.000
TTM5.250YOY4.081+1.169
TTM5.2505Y2.823+2.427
5Y2.82310Y2.202+0.621
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2502.693+2.557
TTM5.2502.697+2.553
YOY4.0813.504+0.577
5Y2.8233.617-0.794
10Y2.2023.499-1.297
1.3.2. Quick Ratio

Measures if Novacyt is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • A Quick Ratio of 4.77 means the company can pay off €4.77 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Novacyt:

  • The MRQ is 4.767. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.767. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.767TTM4.7670.000
TTM4.767YOY3.538+1.229
TTM4.7675Y2.367+2.399
5Y2.36710Y1.745+0.622
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7671.516+3.251
TTM4.7671.658+3.109
YOY3.5382.142+1.396
5Y2.3672.307+0.060
10Y1.7452.370-0.625

1.4. Solvency of Novacyt.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Novacyt assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Novacyt to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.18 means that Novacyt assets are financed with 18.2% credit (debt) and the remaining percentage (100% - 18.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Novacyt:

  • The MRQ is 0.182. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.182. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.182TTM0.1820.000
TTM0.182YOY0.228-0.046
TTM0.1825Y0.336-0.153
5Y0.33610Y0.325+0.011
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1820.402-0.220
TTM0.1820.389-0.207
YOY0.2280.335-0.107
5Y0.3360.442-0.106
10Y0.3250.461-0.136
1.4.2. Debt to Equity Ratio

Measures if Novacyt is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • A Debt to Equity ratio of 22.3% means that company has €0.22 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Novacyt:

  • The MRQ is 0.223. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.223. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.223TTM0.2230.000
TTM0.223YOY0.295-0.072
TTM0.2235Y0.563-0.340
5Y0.56310Y0.519+0.044
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2230.559-0.336
TTM0.2230.560-0.337
YOY0.2950.479-0.184
5Y0.5630.614-0.051
10Y0.5190.674-0.155

2. Market Valuation of Novacyt

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Novacyt generates.

  • Above 15 is considered overpriced but always compare Novacyt to the Medical Devices industry mean.
  • A PE ratio of -2.90 means the investor is paying €-2.90 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Novacyt:

  • The EOD is -1.876. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.898. Based on the earnings, the company is expensive. -2
  • The TTM is -2.898. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.876MRQ-2.898+1.022
MRQ-2.898TTM-2.8980.000
TTM-2.898YOY-27.303+24.405
TTM-2.8985Y-6.448+3.551
5Y-6.44810Y-13.922+7.473
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.876-1.021-0.855
MRQ-2.898-1.704-1.194
TTM-2.898-2.081-0.817
YOY-27.303-2.980-24.323
5Y-6.448-2.379-4.069
10Y-13.922-1.726-12.196
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Novacyt:

  • The EOD is -3.412. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.271. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.271. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.412MRQ-5.271+1.858
MRQ-5.271TTM-5.2710.000
TTM-5.271YOY22.918-28.189
TTM-5.2715Y0.290-5.561
5Y0.29010Y-25.288+25.577
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-3.412-0.981-2.431
MRQ-5.271-1.578-3.693
TTM-5.271-2.973-2.298
YOY22.918-6.179+29.097
5Y0.290-4.928+5.218
10Y-25.288-5.060-20.228
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Novacyt is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.65 means the investor is paying €0.65 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Novacyt:

  • The EOD is 0.419. Based on the equity, the company is cheap. +2
  • The MRQ is 0.647. Based on the equity, the company is cheap. +2
  • The TTM is 0.647. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.419MRQ0.647-0.228
MRQ0.647TTM0.6470.000
TTM0.647YOY1.873-1.226
TTM0.6475Y1.716-1.069
5Y1.71610Y4.599-2.883
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.4191.930-1.511
MRQ0.6472.372-1.725
TTM0.6472.444-1.797
YOY1.8733.205-1.332
5Y1.7163.893-2.177
10Y4.5994.245+0.354
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Novacyt compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.439-0.4390%-0.147-67%0.307-243%0.187-334%
Book Value Per Share--1.9001.9000%2.339-19%1.446+31%0.844+125%
Current Ratio--5.2505.2500%4.081+29%2.823+86%2.202+138%
Debt To Asset Ratio--0.1820.1820%0.228-20%0.336-46%0.325-44%
Debt To Equity Ratio--0.2230.2230%0.295-25%0.563-60%0.519-57%
Dividend Per Share----0%-0%-0%-0%
Eps---0.424-0.4240%-0.160-62%0.283-250%0.092-562%
Free Cash Flow Per Share---0.233-0.2330%0.191-222%0.318-173%0.130-279%
Free Cash Flow To Equity Per Share---0.242-0.2420%0.181-233%0.308-179%0.173-240%
Gross Profit Margin--1.2171.2170%1.722-29%1.360-10%1.244-2%
Intrinsic Value_10Y_max--3.667--------
Intrinsic Value_10Y_min---1.670--------
Intrinsic Value_1Y_max--0.508--------
Intrinsic Value_1Y_min--0.056--------
Intrinsic Value_3Y_max--1.420--------
Intrinsic Value_3Y_min---0.024--------
Intrinsic Value_5Y_max--2.202--------
Intrinsic Value_5Y_min---0.315--------
Market Cap56218455.200-54%86834971.91686834971.9160%309342966.240-72%225530698.311-61%180849005.956-52%
Net Profit Margin---1.055-1.0550%-0.102-90%-0.265-75%-0.541-49%
Operating Margin---0.789-0.7890%-0.014-98%-0.119-85%-0.419-47%
Operating Ratio--1.7891.7890%1.014+76%1.063+68%1.260+42%
Pb Ratio0.419-54%0.6470.6470%1.873-65%1.716-62%4.599-86%
Pe Ratio-1.876+35%-2.898-2.8980%-27.303+842%-6.448+123%-13.922+380%
Price Per Share0.796-54%1.2301.2300%4.380-72%3.193-61%2.561-52%
Price To Free Cash Flow Ratio-3.412+35%-5.271-5.2710%22.918-123%0.290-1919%-25.288+380%
Price To Total Gains Ratio-1.815+35%-2.803-2.8030%-29.859+965%-7.220+158%-2.186-22%
Quick Ratio--4.7674.7670%3.538+35%2.367+101%1.745+173%
Return On Assets---0.158-0.1580%-0.053-66%0.017-1045%-0.153-3%
Return On Equity---0.193-0.1930%-0.069-64%0.023-940%-0.236+22%
Total Gains Per Share---0.439-0.4390%-0.147-67%0.307-243%0.187-334%
Usd Book Value--143612358.879143612358.8790%176767000.021-19%109280404.323+31%63771005.417+125%
Usd Book Value Change Per Share---0.469-0.4690%-0.157-67%0.329-243%0.200-334%
Usd Book Value Per Share--2.0332.0330%2.503-19%1.547+31%0.903+125%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.454-0.4540%-0.172-62%0.302-250%0.098-562%
Usd Free Cash Flow---17631204.141-17631204.1410%14445247.423-222%24005703.987-173%9857690.453-279%
Usd Free Cash Flow Per Share---0.250-0.2500%0.205-222%0.340-173%0.140-279%
Usd Free Cash Flow To Equity Per Share---0.259-0.2590%0.194-233%0.330-179%0.185-240%
Usd Market Cap60164990.755-54%92930786.94592930786.9450%331058842.470-72%241362953.333-61%193544606.174-52%
Usd Price Per Share0.852-54%1.3161.3160%4.687-72%3.417-61%2.740-52%
Usd Profit---27672701.530-27672701.5300%-12125581.752-56%23156557.412-220%7945537.182-448%
Usd Revenue--26225559.21826225559.2180%119386124.613-78%104096955.804-75%56906554.885-54%
Usd Total Gains Per Share---0.469-0.4690%-0.157-67%0.329-243%0.200-334%
 EOD+3 -5MRQTTM+0 -0YOY+8 -265Y+11 -2310Y+10 -24

3.2. Fundamental Score

Let's check the fundamental score of Novacyt based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.876
Price to Book Ratio (EOD)Between0-10.419
Net Profit Margin (MRQ)Greater than0-1.055
Operating Margin (MRQ)Greater than0-0.789
Quick Ratio (MRQ)Greater than14.767
Current Ratio (MRQ)Greater than15.250
Debt to Asset Ratio (MRQ)Less than10.182
Debt to Equity Ratio (MRQ)Less than10.223
Return on Equity (MRQ)Greater than0.15-0.193
Return on Assets (MRQ)Greater than0.05-0.158
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Novacyt based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.567
Ma 20Greater thanMa 500.642
Ma 50Greater thanMa 1000.576
Ma 100Greater thanMa 2000.617
OpenGreater thanClose0.828
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Long-term Assets Other  307-94213-91122-3785-17,200-17,115
Net Interest Income  -926-892-1,818-721-2,5392,191-3481,4171,069



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets140,901
Total Liabilities25,685
Total Stockholder Equity115,216
 As reported
Total Liabilities 25,685
Total Stockholder Equity+ 115,216
Total Assets = 140,901

Assets

Total Assets140,901
Total Current Assets127,238
Long-term Assets13,663
Total Current Assets
Cash And Cash Equivalents 86,973
Short-term Investments 9
Net Receivables 28,530
Other Current Assets 13,294
Total Current Assets  (as reported)127,238
Total Current Assets  (calculated)128,806
+/- 1,568
Long-term Assets
Property Plant Equipment 3,272
Goodwill 6,646
Intangible Assets 3,121
Other Assets 624
Long-term Assets  (as reported)13,663
Long-term Assets  (calculated)13,663
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities24,236
Long-term Liabilities1,449
Total Stockholder Equity115,216
Total Current Liabilities
Short-term Debt 609
Accounts payable 278
Other Current Liabilities 23,349
Total Current Liabilities  (as reported)24,236
Total Current Liabilities  (calculated)24,236
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt263
Other Liabilities 1,186
Long-term Liabilities  (as reported)1,449
Long-term Liabilities  (calculated)1,449
+/-0
Total Stockholder Equity
Common Stock4,053
Retained Earnings 61,445
Other Stockholders Equity 49,718
Total Stockholder Equity (as reported)115,216
Total Stockholder Equity (calculated)115,216
+/-0
Other
Capital Stock4,053
Cash and Short Term Investments 86,982
Common Stock Shares Outstanding 70,626
Liabilities and Stockholders Equity 140,901
Net Debt -86,101
Net Invested Capital 115,216
Net Tangible Assets 105,449
Net Working Capital 103,002
Property Plant and Equipment Gross 3,272
Short Long Term Debt Total 872



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
> Total Assets 
1,647
1,918
1,900
1,509
4,032
3,180
26,588
17,106
30,442
30,205
29,309
26,540
234,276
183,697
140,901
140,901183,697234,27626,54029,30930,20530,44217,10626,5883,1804,0321,5091,9001,9181,647
   > Total Current Assets 
0
0
0
505
2,600
1,904
6,070
5,609
7,360
9,684
9,023
5,897
204,985
158,783
127,238
127,238158,783204,9855,8979,0239,6847,3605,6096,0701,9042,600505000
       Cash And Cash Equivalents 
14
120
109
32
463
840
2,326
527
2,856
3,857
1,020
1,542
91,765
101,746
86,973
86,973101,74691,7651,5421,0203,8572,8565272,3268404633210912014
       Short-term Investments 
244
10
10
42
1,673
1,000
10
1,164
10
9
9
9
9
9
9
999999101,164101,0001,673421010244
       Net Receivables 
427
630
679
331
601
628
2,430
2,030
2,567
4,075
3,994
1,562
88,639
35,870
28,530
28,53035,87088,6391,5623,9944,0752,5672,0302,430628601331679630427
       Other Current Assets 
18
17
12
17
62
29
0
50
53
4,093
5,878
1,118
4,637
18,256
13,294
13,29418,2564,6371,1185,8784,09353500296217121718
   > Long-term Assets 
0
0
0
1,004
1,432
1,275
20,518
11,497
23,082
20,521
20,286
20,643
29,291
24,914
13,663
13,66324,91429,29120,64320,28620,52123,08211,49720,5181,2751,4321,004000
       Property Plant Equipment 
597
582
548
501
444
155
533
683
1,096
1,396
1,073
2,971
3,902
6,382
3,272
3,2726,3823,9022,9711,0731,3961,096683533155444501548582597
       Goodwill 
0
0
0
0
0
0
18,846
9,256
16,466
14,618
14,545
13,599
17,877
11,471
6,646
6,64611,47117,87713,59914,54514,61816,4669,25618,846000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
4
4
0
0
0
0
000044000000000
       Intangible Assets 
203
307
365
493
954
1,051
19,942
1,111
5,333
4,297
4,403
3,685
4,255
3,710
3,121
3,1213,7104,2553,6854,4034,2975,3331,11119,9421,051954493365307203
       Long-term Assets Other 
0
0
0
43
1,679
1,011
19
1,274
180
208
263
183
105
73
-14,695
-14,695731051832632081801,274191,0111,67943000
> Total Liabilities 
1,910
2,572
2,746
2,401
2,393
862
6,061
6,582
12,674
8,087
11,156
14,072
83,566
41,882
25,685
25,68541,88283,56614,07211,1568,08712,6746,5826,0618622,3932,4012,7462,5721,910
   > Total Current Liabilities 
512
824
985
550
1,146
619
4,692
4,335
8,817
6,910
8,920
5,849
74,142
38,904
24,236
24,23638,90474,1425,8498,9206,9108,8174,3354,6926191,146550985824512
       Short-term Debt 
0
0
0
42
1,673
154
10
937
2,983
2,467
2,808
1,379
414
424
609
6094244141,3792,8082,4672,983937101541,67342000
       Short Long Term Debt 
0
0
0
0
0
209
282
1,270
3,499
2,779
3,115
2,190
0
0
0
0002,1903,1152,7793,4991,27028220900000
       Accounts payable 
390
398
467
399
594
295
3,735
1,816
2,087
1,550
2,496
3,922
5,228
1,363
278
2781,3635,2283,9222,4961,5502,0871,8163,735295594399467398390
       Other Current Liabilities 
121
136
124
151
549
319
957
864
2,806
2,893
3,363
505
7,599
12,558
23,349
23,34912,5587,5995053,3632,8932,806864957319549151124136121
   > Long-term Liabilities 
0
0
0
1,850
1,247
244
1,369
2,247
3,857
1,177
2,236
8,223
9,424
2,978
1,449
1,4492,9789,4248,2232,2361,1773,8572,2471,3692441,2471,850000
       Long term Debt Total 
0
0
0
0
0
0
0
0
2,372
960
2,425
8,711
2,359
1,446
0
01,4462,3598,7112,4259602,37200000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
-42
-1,673
-154
-10
-937
-2,983
-2,467
-2,808
1,245
1,964
1,446
263
2631,4461,9641,245-2,808-2,467-2,983-937-10-154-1,673-42000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
946
-2
-1
0
812
0
50
5008120-1-294600000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
186
187
139
315
306
124
69
0
0691243063151391871860000000
> Total Stockholder Equity
0
0
0
0
1,638
2,318
20,527
10,524
17,768
22,117
18,154
12,468
150,710
141,815
115,216
115,216141,815150,71012,46818,15422,11717,76810,52420,5272,3181,6380000
   Retained Earnings 
0
0
0
-2,736
-3,292
-993
-3,702
-22,157
-27,867
-29,570
-34,299
-37,772
96,916
87,188
61,445
61,44587,18896,916-37,772-34,299-29,570-27,867-22,157-3,702-993-3,292-2,736000
   Accumulated Other Comprehensive Income 000-1,893-1,307-2,681-2,432-2,084-2,120-977-544-453000
   Capital Surplus 
0
0
0
0
0
0
0
0
40,557
50,163
56,705
56,455
60,866
50,671
0
050,67160,86656,45556,70550,16340,55700000000
   Treasury Stock00-59-169-173-176-165-980000000



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue21,040
Cost of Revenue-15,294
Gross Profit5,7465,746
 
Operating Income (+$)
Gross Profit5,746
Operating Expense-22,348
Operating Income-16,602-16,602
 
Operating Expense (+$)
Research Development5,047
Selling General Administrative4,856
Selling And Marketing Expenses4,826
Operating Expense22,34814,729
 
Net Interest Income (+$)
Interest Income782
Interest Expense-489
Other Finance Cost-625
Net Interest Income918
 
Pretax Income (+$)
Operating Income-16,602
Net Interest Income918
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-20,053-13,151
EBIT - interestExpense = -17,091
-20,053
-21,712
Interest Expense489
Earnings Before Interest and Taxes (EBIT)-16,602-19,564
Earnings Before Interest and Taxes (EBITDA)-10,066
 
After tax Income (+$)
Income Before Tax-20,053
Tax Provision-2,148
Net Income From Continuing Ops-22,201-22,201
Net Income-22,201
Net Income Applicable To Common Shares-25,730
 
Non-recurring Events
Discontinued Operations-3,529
Extraordinary Items-3,529
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses37,642
Total Other Income/Expenses Net-3,451-918
 

Technical Analysis of Novacyt
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Novacyt. The general trend of Novacyt is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Novacyt's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Novacyt.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.898 < 0.96 < 0.995.

The bearish price targets are: 0.644 > 0.545 > 0.545.

Tweet this
Novacyt Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Novacyt. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Novacyt Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Novacyt. The current macd is 0.07339554.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Novacyt price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Novacyt. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Novacyt price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Novacyt Daily Moving Average Convergence/Divergence (MACD) ChartNovacyt Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Novacyt. The current adx is 51.50.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Novacyt shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Novacyt Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Novacyt. The current sar is 0.69145796.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Novacyt Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Novacyt. The current rsi is 68.57. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Novacyt Daily Relative Strength Index (RSI) ChartNovacyt Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Novacyt. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Novacyt price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Novacyt Daily Stochastic Oscillator ChartNovacyt Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Novacyt. The current cci is 108.17.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Novacyt Daily Commodity Channel Index (CCI) ChartNovacyt Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Novacyt. The current cmo is 35.13.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Novacyt Daily Chande Momentum Oscillator (CMO) ChartNovacyt Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Novacyt. The current willr is -19.83240223.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Novacyt Daily Williams %R ChartNovacyt Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Novacyt.

Novacyt Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Novacyt. The current atr is 0.05529204.

Novacyt Daily Average True Range (ATR) ChartNovacyt Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Novacyt. The current obv is 9,565,607.

Novacyt Daily On-Balance Volume (OBV) ChartNovacyt Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Novacyt. The current mfi is 85.32.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Novacyt Daily Money Flow Index (MFI) ChartNovacyt Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Novacyt.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Novacyt Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Novacyt based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5068.567
Ma 20Greater thanMa 500.642
Ma 50Greater thanMa 1000.576
Ma 100Greater thanMa 2000.617
OpenGreater thanClose0.828
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Novacyt with someone you think should read this too:
  • Are you bullish or bearish on Novacyt? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Novacyt? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Novacyt

I send you an email if I find something interesting about Novacyt.


Comments

How you think about this?

Leave a comment

Stay informed about Novacyt.

Receive notifications about Novacyt in your mailbox!